Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SPCAL-K27 is a multi-ingredient dietary supplement developed by Eridanus Healthcare, formulated to support bone health and mineral metabolism. The product consists of a blend of calcium carbonate, calcitriol (the active form of vitamin D3), vitamin K2-7, methylcobalamin (vitamin B12), magnesium, boron, and zinc. Calcitriol acts as a vitamin D receptor agonist to enhance intestinal calcium absorption, while vitamin K2-7 serves as a cofactor for the carboxylation of osteocalcin, facilitating the integration of calcium into the bone matrix. The additional minerals and vitamins provide structural support and enzymatic cofactors necessary for maintaining bone density and overall skeletal integrity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SPCAL-K27.